G&E Herbal Biotechnology Co., Ltd. (TPEX: 4911)
Consumer Staples · Personal Care Products · TW
NT$27.25
-2.68% today · -38.9% 1Y
G&E Herbal Biotechnology Co., Ltd. (TPEX: 4911) operates in the Personal Care Products industry within the Consumer Staples sector. The company is valued at $57.80M and employs 38 people.
Over the last twelve months the share price has lost 38.9%, trading between 26.80 and 46.48.
Tweenvest scores G&E Herbal Biotechnology Co., Ltd. across four factors: quality 76/100, value 32/100, growth 100/100, dividend 39/100. Its strongest factor is growth.
4911 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $57.80M
- Revenue (TTM)
- $6.78M
- P/E
- 21.81
- EPS
- 1.25
- Dividend yield
- 3.96%
- Beta (5Y)
- -0.73
- 52-week high
- NT$46.48
- 52-week low
- NT$26.80
- Avg volume (3M)
- —
- Shares outstanding
- 68.82M
- Employees
- 38
- Next earnings
- —
About G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
- ISIN
- TW0004911003
- Founded
- 2002
- Listed since
- Mar 21, 2011
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Personal Care Products companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Luo Lih-Fen Holding Co., Ltd.TWSE: 6666 | $62.07M | NT$42.50 | -3.41% |
| Unilever Caribbean LimitedTTSE: UCL | $59.76M | TT$15.35 | -0.97% |
| Comvita LimitedNZSE: CVT | $59.53M | NZ$0.81 | +8.00% |
| Goldenwell Biotech, Inc.OTCPK: GWLL | $59.40M | $0.60 | — |
| Morishita Jintan Co., Ltd.TSE: 4524 | $57.61M | ¥2,219.00 | +0.41% |
| Cizzle Brands CorporationOTCPK: CZZL.F | $56.97M | $0.24 | -9.41% |
| Hantech Bio-Technology Co., Ltd.TPEX: 1294 | $55.25M | NT$49.35 | -0.60% |
| Gin Hwa Biotech IncorporationTPEX: 7806 | $54.97M | NT$55.30 | -7.83% |
Figures last refreshed Oct 18, 2026.